The Framingham Risk Score (FRS) is widely recommended
|
|
- Norman Jones
- 5 years ago
- Views:
Transcription
1 C-Reactive Protein Modulates Risk Prediction Based on the Framingham Score Implications for Future Risk Assessment: Results From a Large Cohort Study in Southern Germany Wolfgang Koenig, MD; Hannelore Löwel, MD; Jens Baumert, MS; Christa Meisinger, MD, MPH Background The Framingham Coronary Heart Disease (CHD) prediction score is recommended for global risk assessment in subjects prone to CHD. Recently, C-reactive protein (CRP) has emerged as an independent predictor of CHD. We sought to assess the potential of CRP measurements to enhance risk prediction based on the Framingham Risk Score (FRS) in a large cohort of middle-aged men from the general population. Methods and Results We measured CRP and traditional cardiovascular risk factors at baseline in 3435 white men of German nationality, 45 to 74 years of age. All men were drawn from 3 random samples of the general population in the Augsburg area located in Southern Germany in 1984 to 1985, 1989 to 1990, and 1994 to 1995 (response rate, 80%), and the FRS was calculated in all of them. Outcome was defined as nonfatal and fatal coronary events, including sudden cardiac death. During an average follow-up of 6.6 years, a total of 191 coronary events occurred. Cox regression showed a significant contribution of CRP to coronary event risk prediction independent of the FRS (P ). In stratified analysis for 5 categories of FRS, CRP significantly added prognostic information to the FRS in subjects in 2 intermediate risk categories (P 0.03 and P 0.02). Conclusions Our results suggest that CRP enhances global coronary risk as assessed by the FRS, especially in intermediate risk groups. This might have implications for future risk assessment. (Circulation. 2004;109: ) Key Words: inflammation risk factors coronary disease epidemiology prevention The Framingham Risk Score (FRS) is widely recommended to assess global risk for coronary heart disease (CHD) events. 1 However, classic risk factors do not account for all incident coronary events, and there may be a substantial number of subjects with normal lipoprotein concentrations who have the disease. 2 This has led to the search for additional diagnostic tools, 3 and in more than 15 large prospective studies, C-reactive protein (CRP), through the use of new high-sensitivity (hs) assays, has emerged as a strong and consistent predictor of an incident cardiovascular event in initially healthy subjects. 4 A recent prospective study in women has suggested that CRP may even better predict future cardiovascular events than LDL cholesterol 2 and that it may add to the prediction of the estimated 10-year risk according to the FRS. We sought to investigate the potential of CRP measurements to modify risk prediction based on the FRS in a large CHD-event free cohort of middle-aged white men of German nationality sampled from the general population. Methods Study Design, Population, and Follow-Up The population-based MONICA (MONItoring of trends and determinants in CArdiovascular disease) Augsburg studies (Southern Germany) conducted between 1984 and 1998 were used as the database. 5 Three independent cross-sectional surveys covering the city of Augsburg and two adjacent counties were conducted in 1984 to 1985 (S1), 1989 to 1990 (S2), and 1994 to 1995 (S3) to estimate the prevalence of cardiovascular risk factors among men and women. Altogether, 13,428 white subjects of German nationality (6725 men, 6703 women; response rate, 77%), 25 to 74 years of age, randomly drawn from the general population, participated in at least one of the three studies. In a follow-up study, vital status was assessed for all persons of the three surveys in During the observation period, 772 participants (531 men, 241 women) had died, and vital status could not be assessed for 56 persons (31 men, 25 women) who had moved to an unknown location. The outcome variable was a combination of incident fatal or nonfatal acute myocardial infarction (MI) and sudden cardiac death. They were identified through the MONICA/KORA (KOoperative Gesundheitsforschung in der Region Augsburg) coronary event Received April 25, 2003; de novo received October 28, 2003; revision received December 17, 2003; accepted December 29, From the Department of Internal Medicine II, Cardiology, University of Ulm Medical Center, Ulm, Germany (W.K.); GSF, National Research Center for Environment and Health, Institute of Epidemiology, Neuherberg, Germany (H.L., J.B., C.M.); and MONICA/KORA Coronary Event Register, Central Hospital, Augsburg, Germany (H.L., C.M.). Correspondence to Wolfgang Koenig, MD, Department of Internal Medicine II, Cardiology, University of Ulm Medical Center, Robert-Koch Str 8, D Ulm, Germany. wolfgang.koenig@medizin.uni-ulm.de 2004 American Heart Association, Inc. Circulation is available at DOI: /01.CIR E3 1349
2 1350 Circulation March 23, 2004 TABLE 1. Age- and Survey-Adjusted Means and Prevalences (%) for Men With and Without Incident Coronary Event: MONICA/KORA Augsburg Cohort Study, 1984 to 1998 register of the 25- to 74-year-old study population and censored at the 75th year of age. 6 According to the MONICA manual, 5 the diagnosis of a major nonfatal MI event was based on symptoms, cardiac enzymes, and typical ECG changes. Deaths from cardiovascular causes were validated by autopsy reports, death certificates, chart review, and information from the last treating physician. The present analysis was restricted to men 45 to 74 years of age (response rate, 80%) at the baseline examination (n 3667). Of those, 990 (27%) subjects were from survey S1, 1324 (36%) from S2, and 1353 (37%) from S3. A total of 48 subjects had missing values on CRP or other variables. Participants with prevalent MI (n 184) were excluded. Thus, 3435 subjects were available for the present analysis. Survey Methods All participants completed a standardized questionnaire, including medical history, lifestyle, and drug history. Blood pressure, body height (meters) and body weight (kilograms), body mass index (BMI, kg/m 2 ), smoking behavior, and alcohol consumption (g/d) were determined as described elsewhere. 7 The number of education years was calculated on the basis of the highest level of formal education completed. Laboratory Procedures A nonfasting venous blood sample was collected from all participants in a supine resting position. Samples for measurement of CRP were stored at 70 C until analysis. Serum CRP concentrations were measured with the use of an hs-immunoradiometric assay (range, 0.05 to 10 mg/l), as previously described. 8 The coefficient of variation (CV) for repeated measurements was 12% over all ranges. Men With Event (n 191) Men Without Event (n 3244) P Age,* y TC/HDL-C ratio (antilog) CRP, mg/l (antilog) Cholesterol In mg/dl In mmol/l HDL-C In mg/dl In mmol/l Systolic blood pressure, mm Hg Diastolic blood pressure, mm Hg BMI, kg/m Normal weight (BMI 25.0 kg/m 2 ), % Overweight (BMI 25 to 29.9 kg/m 2 ), % Obesity (BMI 30.0 kg/m 2 ), % Alcohol intake, % 0 g/d to 39.9 g/d g/d History of diabetes (yes), % Education ( 12 y), % Physical activity ( 1 h/wk), % Current smoker, % *Only survey-adjusted. Total serum cholesterol (TC) and HDL cholesterol (HDL-C) were measured in multiple batches by routine enzymatic methods. Corresponding CVs were between 1% and 3% for TC and between 3% and 4% for HDL-C. Statistical Analysis Means or proportions (adjusted for age and survey) for baseline demographic and clinical characteristics were computed by AN- COVA for men with and without incident coronary events. Cox proportional hazards analysis was used to assess the independent risk for the incidence of a first fatal or nonfatal acute coronary event separately in quartiles of TC/HDL-C and in quartiles of CRP. Relative risks for both variables were adjusted for age and survey (S1, S2, or S3) and were further adjusted for BMI (according to Bray, 7), current smoking (yes/no), hypertension (blood pressure less than versus 140/90 mm Hg), education years (less than versus 12 years), alcohol consumption (0, 0.1 to 39.9, versus 40 g/d), physical activity (inactive versus active, that is, 1 hour in at least 1 season), and history of diabetes (yes versus no) in all other models. Results are presented as hazard ratios (HR), together with their 95% confidence intervals. Probability values are based on the Wald statistic. Finally, using Cox proportional hazards analysis, we assessed whether CRP contributed information on risk beyond that conveyed by the 10-year risk calculated with the FRS according to the formula of Wilson et al 9 and beyond the risk associated with the ratio of TC/HDL-C. In these analyses, CRP concentrations were categorized according to recently proposed cut-points ( 1.0 mg/l; 1.0 to 3.0 mg/l; 3.0 mg/l). 10 Moreover, to estimate the effects of the additional value of CRP on the prediction of coronary events in
3 Koenig et al CRP Adds to Framingham Risk Score 1351 TABLE 2. Risk of a First Coronary Event Estimated by Cox Proportional Hazards Model Without and With CRP for the Ratio of TC/HDL-C (A) and the Framingham Risk Score With Three Categories (B) and Five Categories (C) Model Without CRP Model With CRP Factor Events/n HR (95% CI) P HR (95% CI) P A TC/HDL-C ratio /1100 Reference Reference 4.3 to / ( ) 1.18 ( ) / ( ) 1.80 ( ) CRP, mg/l to 3 64/ ( ) 3 90/ ( ) AIC AIC: 29 AUC B FRS 1, % /809 Reference Reference 6 to / ( ) 2.39 ( ) 20 56/ ( ) 4.85 ( ) CRP, mg/l to 3 64/ ( ) 3 90/ ( ) AIC AIC: 19 AUC C FRS 2, % /809 Reference Reference 6 to 10 32/ ( ) 1.46 ( ) 11 to 14 35/ ( ) 2.35 ( ) 15 to 19 50/ ( ) 4.50 ( ) 20 56/ ( ) 5.01 ( ) CRP, mg/l to 3 64/ ( ) 3 90/ ( ) AIC AIC: 13 AUC different FRS categories, separate Cox proportional hazards analyses stratified for FRS categories (3 or 5, respectively) were performed. For each of the 3, respective 5 FRS categories, a Cox proportional hazards model was calculated with the inclusion of CRP (3 categoreis) as exposition variable and FRS (continuous) and survey as confounding covariates. The percentages of a first incident coronary event within 10 years estimated by these Cox models were compared according to percentages estimated by Cox models with FRS categories (3 or 5, respectively) adjusted only for survey. To assess the goodness of fit of the different prediction models, we calculated Akaike s Information Criterion (AIC) regarding an AIC difference between two models of 10 as essentially different. 11,12 Although ROC analysis can be only a rough estimate for the predictive value of a Cox proportional hazards model in our study design with censored data, we performed such analysis for reasons of comparison with other studies. We estimated the area under the curve (AUC) as a measure for the predictive ability of a Cox proportional hazards model. Different AUCs were tested by a nonparametric approach of DeLong et al. 13 The change-inestimate method (CIE) was used to evaluate the impact of the addition of CRP on the HRs of the FRS with a 10% criterion. 14 Significance tests are 2 tailed, and probability values 0.05 were considered statistically significant. All analyses were performed with the use of the Statistical Analysis System (Version 8.2 for Unix, SAS Institute Inc).
4 1352 Circulation March 23, 2004 Occurrence of a first coronary event within 10 years, estimated by Cox proportional hazards models in percentages. Left, Percentage estimated by a model with FRS (5 categories) adjusted for survey. Right, Percentage estimated for each of 5 FRS categories by a model with CRP (3 categories) adjusted for FRS (continuous) and survey. Probability values indicate significance status of CRP in the Cox model. MONICA/KORA- Augsburg Cohort Study, 1984 to Results Baseline Characteristics During an average follow-up of 6.6 years, a total of 191 coronary events occurred. Men with an incident event were significantly older; had a higher TC/HDL-C ratio, higher systolic blood pressures, and elevated CRP concentrations; were more frequently smokers; and had a higher prevalence of obesity and diabetes (Table 1). Relative Risks Associated With CRP and the Ratio of TC/HDL-C In multivariable analyses, the relative risks associated with increasing quartiles as compared with the bottom quartiles were 1.21, 1.43, and 2.03 for CRP (P ) and 1.72, 1.76, and 2.62 for the ratio of TC/HDL-C (P ). Additive Effect of CRP to the Risk Associated With the Ratio of TC/HDL-C and the FRS We performed Cox proportional hazards analyses to assess the influence of CRP measurements on the risk of a first coronary event, independent of the TC/HDL-C ratio and the calculated FRS. For this purpose, TC/HDL-C was categorized into tertiles and the FRS was divided into low ( 6%), intermediate (6% to 19%), and high ( 20%) risk over 10 years (FRS 1), according to Greenland et al, 15 and into 5 risk categories 6%, 6% to 10%, 11% to 14%, 15% to 19%, and 20% (FRS 2) (Table 2). For each of these factors, two Cox regression models were calculated: The first model included only the factor under concern as covariate (model without CRP) and the second model additionally included CRP as covariate (model with CRP). As shown in Table 2, CRP significantly contributed to the prediction of incident coronary events through the use of the TC/HDL-C ratio, FRS 1, and FRS 2 (probability values 0.001). As suggested by AIC, with differences 10 between models without CRP and those including CRP, the fit of each model containing CRP was superior to that of the TC/HDL-C ratio and FRS alone. The AUC as a rough estimate (in our study design) for the predictive value of the different Cox models revealed a statistically significant increase from (model with FRS 2) to (model with FRS 2 and CRP) (P ). The inclusion of CRP was associated with a remarkable decrease in the HR of the FRS. The HR of the highest FRS 2 category (risk 20%/10 years) compared with the lowest FRS 2 category (risk 6%/10 years) decreased from 6.2 to 5.0, indicating a CIE of 19.4%. All CIEs are greater than the 10% criterion, indicating a strong impact of CRP on the HRs of FRS 2. Similar results were observed for the FRS 1 model. Moreover, we compared the proportions of incident coronary events within 10 years estimated by the Cox model for the five categories of FRS 2 alone (Figure, left panel) and for different CRP categories in each category of FRS 2, adjusted for survey and FRS (Figure, right panel). Probability values of the stratified analyses are given in the Figure (right panel, above each FRS category). Cox regression revealed a considerable modification in coronary event incidence based on CRP concentrations and, more importantly, in categories of FRS 2 associated with a 10% to 20% risk per 10 years, elevated concentrations of CRP were consistently and statistically significantly associated with a further increased risk (P 0.03 and P 0.02). In contrast, in men with a risk 6% and 6% to 10% per 10 years, CRP had no statistically significant additional effect on the prediction of a first coronary event. Regarding the different AUCs, a remarkable increase was found for the intermediate FRS categories of 11% to 14% and 15% to 19% (increase in the AUC from to and from to 0.751). Discussion In this prospective population-based study, increased CRP concentrations and an elevated TC/HDL-C ratio were both independently related to incident coronary events. However, even if the strongest lipid/lipoprotein variable was chosen for risk assessment, our data clearly show that the measurement
5 Koenig et al CRP Adds to Framingham Risk Score 1353 of CRP contributes significantly to the prediction of a first coronary event and adds clinically relevant information to the TC/HDL-C ratio. Finally, and most importantly, these prospective data from a large European cohort of middle-aged men clearly suggest that CRP modulates the risk conveyed by the FRS as the HRs from the top to the bottom category decreased remarkably after inclusion of CRP in the various models. This was observed in particular in those with an FRS between 10% and 20% over a period of 10 years. These men may benefit from additional noninvasive tests such as determination of CRP by a hs assay. Such conclusions are in agreement with recent findings by Albert et al. 16 They found significant correlations between CRP concentrations and the FRS but only minimal correlations with its individual components. However, our data are in contrast to a report from the Rotterdam Study, 17 which found no additional value of CRP in elderly people. Such discrepancy may be explained by differences in age, the additional inclusion of left ventricular hypertrophy, another important risk marker, and the fact that CRP concentrations in incident cases were considerably lower than in our study despite the older average age in the Rotterdam population. In summary, our data confirm and extend results from the Women s Health Study 2 in a large sample of men from the general population. If these findings can be replicated in other populations, this may represent a strong argument for the inclusion of CRP as an additional variable to further improve risk prediction in asymptomatic subjects at intermediate risk of CHD. This would be in line with recent American Heart Association/Centers for Disease Control guidelines. 10 Acknowledgments The authors thank Gerlinde Trischler for excellent technical assistance and Andrea Schneider for expert data handling. We also thank Lloyd Chambless for critical comments on the revised manuscript. References 1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285: Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347: Pearson TA. New tools for coronary risk assessment: what are their advantages and limitations? Circulation. 2002;105: Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107: WHO-MONICA-Project Principal Investigators. The World Health Organization MONICA Project (Monitoring Trends and Determinants in Cardiovascular Disease). J Clin Epidemiol. 1988;41: Loewel H, Lewis M, Hoermann A, et al. Case finding, data quality aspects and comparability of myocardial infarction registers: results of a south German register study. J Clin Epidemiol. 1991;44: Hense HW, Filipiak B, Döring A, et al. Ten-year trends of cardiovascular risk factors in the MONICA Augsburg region in southern Germany. Results from 1984/1985, 1989/1990, and 1994/1995 surveys. CVD Prevention. 1998;1: Hutchinson WL, Koenig W, Fröhlich M, et al. Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. Clin Chem. 2000;46: Wilson PWF, D Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97: Pearson TA, Mensah GA, Alexander WR, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the Am Heart Association. Circulation. 2003;107: Akaike H. Information theory as a extension of the maximum likelihood principle. In: Pterov BN, Csaki F, eds. Second International Symposium on Information Theory. Budapest, Hungary: Akademiai Kiado; 1973: Burnham KP, Anderson DR. Model selection and inference: a practical information-theoretic approach. New York, NY: Springer; 1998: DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44: Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health. 1989;79: Greenland P, Smith SC, Grundy SM. Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation. 2001;104: Albert MA, Glynn RJ, Ridker PM. Plasma concentration of C-reactive protein and the calculated Framingham coronary heart disease risk score. Circulation. 2003;108: van der Meer IM, de Maat MP, Kiliaan AJ, et al. The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study. Arch Intern Med. 2003;163:
The Framingham Coronary Heart Disease Risk Score
Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Although
More informationORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults
ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen
More informationLong-term prognostic value of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) changes within one year in patients with coronary heart disease
Long-term prognostic value of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) changes within one year in patients with coronary heart disease D. Dallmeier 1, D. Rothenbacher 2, W. Koenig 1, H. Brenner
More informationHigh-sensitivity Troponin T Predicts Recurrent Cardiovascular Events in Patients with Stable Coronary Heart Disease: KAROLA Study 8 Year FU
ESC Congress 2011 Paris, France, August 27-31 KAROLA Session: Prevention: Are biomarkers worth their money? Abstract # 84698 High-sensitivity Troponin T Predicts Recurrent Cardiovascular Events in Patients
More informationJournal of the American College of Cardiology Vol. 48, No. 7, by the American College of Cardiology Foundation ISSN /06/$32.
Journal of the American College of Cardiology Vol. 48, No. 7, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.06.053
More informationCentral pressures and prediction of cardiovascular events in erectile dysfunction patients
Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,
More informationAssessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients. Copyright. Not for Sale or Commercial Distribution
CLINICAL Viewpoint Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients Copyright Not for Sale or Commercial Distribution By Ruth McPherson, MD, PhD, FRCPC Unauthorised
More informationCorrelation of novel cardiac marker
Correlation of novel cardiac marker and mortality in EGAT population. Soluble ST2 hscrp Poh Chanyavanich, MD SukitYamwong, MD Piyamitr Sritara, MD Ramathibodi hospital Background hscrp - the most widely
More informationAssessing Cardiovascular Disease Risk with HS-C-reactive. California Technology Assessment Forum
TITLE: Assessing Cardiovascular Disease Risk with HS-C-reactive Protein AUTHOR: Judith Walsh, M.D., MPH Professor of Medicine Division of General Internal Medicine Department of Medicine University of
More informationYOUNG ADULT MEN AND MIDDLEaged
BRIEF REPORT Favorable Cardiovascular Profile in Young Women and Long-term of Cardiovascular and All-Cause Mortality Martha L. Daviglus, MD, PhD Jeremiah Stamler, MD Amber Pirzada, MD Lijing L. Yan, PhD,
More information(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects
Table 1. Distribution of baseline characteristics across tertiles of OPG adjusted for age and sex (n=6279). Continuous variables are reported as mean with 95% confidence interval and categorical values
More informationJUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study
Panel Discussion: Literature that Should Have an Impact on our Practice: The Study Kaiser COAST 11 th Annual Conference Maui, August 2009 Robert Blumberg, MD, FACC Ralph Brindis, MD, MPH, FACC Primary
More information1. Which one of the following patients does not need to be screened for hyperlipidemia:
Questions: 1. Which one of the following patients does not need to be screened for hyperlipidemia: a) Diabetes mellitus b) Hypertension c) Family history of premature coronary disease (first degree relatives:
More informationFatality of Future Coronary Events Is Related to Inflammation-Sensitive Plasma Proteins
Fatality of Future Coronary Events Is Related to Inflammation-Sensitive Plasma Proteins A Population-Based Prospective Cohort Study Gunnar Engström, MD; Bo Hedblad, MD; Lars Stavenow, MD; Patrik Tydén,
More informationSupplementary Online Content
Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines
More informationOptimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden
Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD
More informationA: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups
A: Epidemiology update Evidence that LDL-C and CRP identify different high-risk groups Women (n = 27,939; mean age 54.7 years) who were free of symptomatic cardiovascular (CV) disease at baseline were
More informationSupplementary Online Content
Supplementary Online Content Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA Intern Med. Published online November 7, 2016.
More informationC-Reactive Protein and Electrocardiographic ST-Segment Depression Additively Predict Mortality The Strong Heart Study
Journal of the American College of Cardiology Vol. 45, No. 11, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.02.072
More informationSubclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD
Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Sao Paulo Medical School Sao Paolo, Brazil Subclinical atherosclerosis in CVD risk: Stratification & management Prof.
More informationC-REACTIVE PROTEIN AND LDL CHOLESTEROL FOR PREDICTING CARDIOVASCULAR EVENTS
COMPARISON OF C-REACTIVE PROTEIN AND LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS IN THE PREDICTION OF FIRST CARDIOVASCULAR EVENTS PAUL M. RIDKER, M.D., NADER RIFAI, PH.D., LYNDA ROSE, M.S., JULIE E. BURING,
More informationNormal Fasting Plasma Glucose and Risk of Type 2 Diabetes Diagnosis
CLINICAL RESEARCH STUDY Normal Fasting Plasma Glucose and Risk of Type 2 Diabetes Diagnosis Gregory A. Nichols, PhD, Teresa A. Hillier, MD, MS, Jonathan B. Brown, PhD, MPP Center for Health Research, Kaiser
More informationJohn J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam
Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention
More informationVal-MARC: Valsartan-Managing Blood Pressure Aggressively and Evaluating Reductions in hs-crp
Página 1 de 5 Return to Medscape coverage of: American Society of Hypertension 21st Annual Scientific Meeting and Exposition Val-MARC: Valsartan-Managing Blood Pressure Aggressively and Evaluating Reductions
More informationThe Whitehall II study originally comprised 10,308 (3413 women) individuals who, at
Supplementary notes on Methods The study originally comprised 10,308 (3413 women) individuals who, at recruitment in 1985/8, were London-based government employees (civil servants) aged 35 to 55 years.
More informationLipoprotein-Associated Phospholipase A2 Is an Independent Predictor of Incident Coronary Heart Disease in an Apparently Healthy Older Population
Journal of the American College of Cardiology Vol. 51, No. 9, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2007.10.048
More informationSummary HTA. HTA-Report Summary
Summary HTA HTA-Report Summary Prognostic value, clinical effectiveness and cost-effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac events Schnell-Inderst
More informationARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:
ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized
More informationCVD risk assessment using risk scores in primary and secondary prevention
CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities
More informationCoronary heart disease (CHD) is the leading cause of
Serum Albumin and Risk of Myocardial Infarction and All-Cause Mortality in the Framingham Offspring Study Luc Djoussé, MD, DSc; Kenneth J. Rothman, DrPH; L. Adrienne Cupples, PhD; Daniel Levy, MD; R. Curtis
More informationWeintraub, W et al NEJM March Khot, UN et al, JAMA 2003
Global risk hscrp Should not be included in a Global Cardiovascular Risk Assessment. Jodi Tinkel, MD Assistant Professor Director of Cardiac Rehabilitation Associate Program Director, Cardiovascular Medicine
More informationDiabetes, Diet and SMI: How can we make a difference?
Diabetes, Diet and SMI: How can we make a difference? Dr. Adrian Heald Consultant in Endocrinology and Diabetes Leighton Hospital, Crewe and Macclesfield Research Fellow, Manchester University Relative
More informationGALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS
GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS Table of Contents List of authors pag 2 Supplemental figure I pag 3 Supplemental figure II pag 4 Supplemental
More informationLDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC
Am J Cardiol (2004);94:729-32 Relation of degree of physical activity to coronary artery calcium score in asymptomatic individuals with multiple metabolic risk factors M. Y. Desai, et al. Ciccarone Preventive
More informationSerum c-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population
Journal of Internal Medicine 2005; 258: 527 535 doi:10.1111/j.1365-2796.2005.01572.x Serum c-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population C. MEISINGER
More informationSupplementary Online Content
Supplementary Online Content Li S, Chiuve SE, Flint A, et al. Better diet quality and decreased mortality among myocardial infarction survivors. JAMA Intern Med. Published online September 2, 2013. doi:10.1001/jamainternmed.2013.9768.
More informationCVD Prevention, Who to Consider
Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..
More informationTreatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center
Treatment of Cardiovascular Risk Factors Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Disclosures: None Objectives What do risk factors tell us What to check and when Does treatment
More informationSupplementary Online Content
Supplementary Online Content Åsvold BO, Vatten LJ, Bjøro T, et al; Thyroid Studies Collaboration. Thyroid function within the normal range and risk of coronary heart disease: an individual participant
More informationThe JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009
The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009 Learning Objectives 1. Understand the role of statin therapy in the primary and secondary prevention of stroke 2. Explain
More informationRisk Factors for Heart Disease
Risk Factors for Heart Disease Risk Factors we cannot change (Age, Gender, Family History) Risk Factors we can change (modifiable) Smoking Blood pressure Cholesterol Diabetes Inactivity Overweight Stress
More informationAtherosclerotic Disease Risk Score
Atherosclerotic Disease Risk Score Kavita Sharma, MD, FACC Diplomate, American Board of Clinical Lipidology Director of Prevention, Cardiac Rehabilitation and the Lipid Management Clinics September 16,
More informationDiabetes Care 31: , 2008
Cardiovascular and Metabolic Risk O R I G I N A L A R T I C L E Global Coronary Heart Disease Risk Assessment of Individuals With the Metabolic Syndrome in the U.S. KHIET C. HOANG, MD HELI GHANDEHARI VICTOR
More informationGuidelines on cardiovascular risk assessment and management
European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine
More informationKnow Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
More informationAndrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION
2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL
More informationThe Metabolic Syndrome: Is It A Valid Concept? YES
The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA
More informationPrevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values
Papers in Press. First published June 17, 2004 as doi:10.1373/clinchem.2004.036004 Clinical Chemistry 50:9 000 000 (2004) Lipids, Lipoproteins, and Cardiovascular Risk Factors Prevalence of High C-Reactive
More informationJournal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32.
Journal of the American College of Cardiology Vol. 48, No. 2, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.03.043
More informationElevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 Diabetes
Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E Elevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 Diabetes FRANK B. HU, MD 1,2,3 MEIR J. STAMPFER,
More informationImportance of a Patient s Personal Health History on Assessments of Future Risk of Coronary Heart Disease
Importance of a Patient s Personal Health History on Assessments of Future Risk of Coronary Heart Disease Arch G. Mainous, III, PhD, Charles J. Everett, PhD, Marty S. Player, MD, MS, Dana E. King, MD,
More informationAdherence to a healthy diet in relation to cardiovascular incidence and risk markers: evidence from the Caerphilly Prospective Study
DOI 10.1007/s00394-017-1408-0 ORIGINAL CONTRIBUTION Adherence to a healthy diet in relation to cardiovascular incidence and risk markers: evidence from the Caerphilly Prospective Study Elly Mertens 1,2
More informationImpaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events
Diabetes Care Publish Ahead of Print, published online May 28, 2008 Chronotropic response in patients with diabetes Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts
More informationAssociation Between Consumption of Beer, Wine, and Liquor and Plasma Concentration of High-Sensitivity C-Reactive Protein in Women Aged 39 to 89 Years
Association Between Consumption of Beer, Wine, and Liquor and Plasma Concentration of High-Sensitivity C-Reactive Protein in Women Aged 39 to 89 Years Emily B. Levitan, MS a,e, Paul M. Ridker, MD, MPH
More informationSupplementary Online Content
Supplementary Online Content McEvoy JW, Chen Y, Ndumele CE, et al. Six-year change in high-sensitivity cardiac troponin T and risk of subsequent coronary heart disease, heart failure, and death. JAMA Cardiol.
More informationTable S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416).
Table S1. Characteristics associated with frequency of nut (full entire sample; Nn=4,416). Daily nut Nn= 212 Weekly nut Nn= 487 Monthly nut Nn= 1,276 Infrequent or never nut Nn= 2,441 Sex; n (%) men 52
More informationInflammation and and Heart Heart Disease in Women Inflammation and Heart Disease
Inflammation and Heart Disease in Women Inflammation and Heart Disease What is the link between een inflammation and atherosclerotic disease? What is the role of biomarkers in predicting cardiovascular
More informationPreventing Cardiovascular Disease With Lipid Management: Matching Therapy to Risk
PREVENTING CARDIOVASCULAR DISEASE WITH LIPID MANAGEMENT : MATCHING TREATMENT TO RISK Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict
More informationthe U.S. population, have some form of cardiovascular disease. Each year, approximately 6 million hospitalizations
Cardioprotection: What is it? Who needs it? William B. Kannel, MD, MPH From the Department of Preventive Medicine and Epidemiology, Evans Department of Clinical Research, Boston University School of Medicine,
More informationNon-fasting lipids and risk of cardiovascular disease in patients with diabetes mellitus
Diabetologia (2011) 54:73 77 DOI 10.1007/s00125-010-1945-z SHORT COMMUNICATION Non-fasting lipids and risk of cardiovascular disease in patients with diabetes mellitus S. van Dieren & U. Nöthlings & Y.
More informationCARDIOVASCULAR DISEASE RISK FACTOR ESTIMATION IN GUJARATI ASIAN INDIAN POPULATION USING FRAMINGHAM RISK EQUATION
ORIGINAL ARTICLE CARDIOVASCULAR DISEASE RISK FACTOR ESTIMATION IN GUJARATI ASIAN INDIAN POPULATION USING FRAMINGHAM RISK EQUATION Sibasis Sahoo 1, Komal Shah 2,Anand Shukla 3, Jayesh Prajapati 3, Pratik
More informationGlobal Coronary Heart Disease Risk Assessment of U.S. Persons With the Metabolic. Syndrome. and Nathan D. Wong, PhD, MPH
Diabetes Care Publish Ahead of Print, published online April 1, 2008 Global Coronary Heart Disease Risk Assessment of U.S. Persons With the Metabolic Syndrome Khiet C. Hoang MD, Heli Ghandehari, BS, Victor
More informationHigh Density Lipoprotein Cholesterol and Mortality
High Density Lipoprotein Cholesterol and Mortality The Framingham Heart Study Peter W.F. Wilson, Robert D. Abbott, and William P. Castelli In 12 years of follow-up for 2748 Framingham Heart Study participants
More informationPreventing Myocardial Infarction in the Young Adult in the First Place: How Do the National Cholesterol Education Panel III Guidelines Perform?
Journal of the American College of Cardiology Vol. 41, No. 9, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00187-6
More informationBiases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University
Biases in clinical research Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Learning objectives Describe the threats to causal inferences in clinical studies Understand the role of
More informationAssociation between C-reactive protein and Incidence of Type-2 Diabetes in a Japanese Worksite-based Cohort
Association between C-reactive protein and Incidence of Type-2 Diabetes in a Japanese Worksite-based Cohort Chaochen Wang 1, Hiroshi Yatsuya 1, Koji Tamakoshi 1, Hideaki Toyoshima 2, Yuanying Li 3,Kentaro
More informationjournal of medicine The new england Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein Abstract
The new england journal of medicine established in 1812 november 20, 2008 vol. 359 no. 21 to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein Paul M Ridker, M.D., Eleanor Danielson,
More informationORIGINAL INVESTIGATION. Relation of Triglyceride Levels, Fasting and Nonfasting, to Fatal and Nonfatal Coronary Heart Disease
ORIGINAL INVESTIGATION Relation of Triglyceride Levels, Fasting and Nonfasting, to Fatal and Nonfatal Coronary Heart Disease Lynn E. Eberly, PhD; Jeremiah Stamler, MD; James D. Neaton, PhD; for the Multiple
More informationChemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study,
Diabetologia (2006) 49: 921 929 DOI 10.1007/s00125-006-0190-y ARTICLE C. Herder. J. Baumert. B. Thorand. W. Koenig. W. de Jager C. Meisinger. T. Illig. S. Martin. H. Kolb Chemokines as risk factors for
More informationReview of guidelines for management of dyslipidemia in diabetic patients
2012 international Conference on Diabetes and metabolism (ICDM) Review of guidelines for management of dyslipidemia in diabetic patients Nan Hee Kim, MD, PhD Department of Internal Medicine, Korea University
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Rawshani Aidin, Rawshani Araz, Franzén S, et al. Risk factors,
More informationAutonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors
Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Carmine Pizzi 1 ; Lamberto Manzoli 2, Stefano Mancini 3 ; Gigliola Bedetti
More informationHow would you manage Ms. Gold
How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56
More informationSmall dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study
Small dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study Hidenori Arai 1, Yoshihiro Kokubo 2, Makoto Watanabe 2, Tatsuya Sawamura 3, Tomonori
More informationCVD risk calculation
CVD risk calculation Cardiovascular disease (CVD) is the most common cause of death in Alberta, accounting for nearly one third (31%) of the overall deaths (1). The majority (90%) of the CVD cases are
More informationCARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES
CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES C. Liakos, 1 G. Vyssoulis, 1 E. Karpanou, 2 S-M. Kyvelou, 1 V. Tzamou, 1 A. Michaelides, 1 A. Triantafyllou, 1 P. Spanos, 1 C. Stefanadis
More informationTraitements associés chez l hypertendu: Statines, Aspirine
Traitements associés chez l hypertendu: Statines, Aspirine Pr Jean-Jacques Mourad CHU Avicenne, Université Paris 13, Bobigny DU HTA, Mars 2012 jean-jacques.mourad@avc.aphp.fr Global Mortality 2000: Impact
More informationFolate, vitamin B 6, and vitamin B 12 are cofactors in
Research Letters Dietary Folate and Vitamin B 6 and B 12 Intake in Relation to Mortality From Cardiovascular Diseases Japan Collaborative Cohort Study Renzhe Cui, MD; Hiroyasu Iso, MD; Chigusa Date, MD;
More information300 Biomed Environ Sci, 2018; 31(4):
300 Biomed Environ Sci, 2018; 31(4): 300-305 Letter to the Editor Combined Influence of Insulin Resistance and Inflammatory Biomarkers on Type 2 Diabetes: A Population-based Prospective Cohort Study of
More informationD Terentes-Printzios, C Vlachopoulos, G Vyssoulis, N Ioakeimidis, P Xaplanteris, K Aznaouridis, E Christoforatou, A Samentzas, A Siama, C Stefanadis
Peripheral Vessels Unit, 1st Department of Cardiology Athens Medical School Hippokration Hospital, Athens, Greece D Terentes-Printzios, C Vlachopoulos, G Vyssoulis, N Ioakeimidis, P Xaplanteris, K Aznaouridis,
More informationNorthwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient?
Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient? Donald M. Lloyd-Jones, MD, ScM, FACC, FAHA Senior Associate Dean Chair, Department of Preventive
More informationFamily history of premature coronary heart disease and risk prediction in the EPIC-Norfolk prospective population study
1 Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands 2 Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands 3 Department of Public Health and
More informationIdentification of subjects at high risk for cardiovascular disease
Master Class in Preventive Cardiology Focus on Diabetes and Cardiovascular Disease Geneva April 14 2011 Identification of subjects at high risk for cardiovascular disease Lars Rydén Karolinska Institutet
More informationEpidemiologic Measure of Association
Measures of Disease Occurrence: Epidemiologic Measure of Association Basic Concepts Confidence Interval for population characteristic: Disease Exposure Present Absent Total Yes A B N 1 = A+B No C D N 2
More informationCardiovascular Disease Prevention: Current Knowledge, Future Directions
Cardiovascular Disease Prevention: Current Knowledge, Future Directions Daniel Levy, MD Director, Framingham Heart Study Professor of Medicine, Boston University School of Medicine Editor-in-Chief, Journal
More informationI t is established that regular light to moderate drinking is
32 CARDIOVASCULAR MEDICINE Taking up regular drinking in middle age: effect on major coronary heart disease events and mortality S G Wannamethee, A G Shaper... See end of article for authors affiliations...
More informationSCIENTIFIC STUDY REPORT
PAGE 1 18-NOV-2016 SCIENTIFIC STUDY REPORT Study Title: Real-Life Effectiveness and Care Patterns of Diabetes Management The RECAP-DM Study 1 EXECUTIVE SUMMARY Introduction: Despite the well-established
More informationBeyond Framingham: Risk Assessment & Treatment for Primary Prevention
Beyond Framingham: Risk Assessment & Treatment for Primary Prevention Ronald M. Goldenberg, MD, FRCPC, FACE Consultant Endocrinologist, North York General Hospital Medical Co-Director, LMC Endocrinology
More informationPreventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex
Prevention and Rehabilitation Preventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex Nathan D. Wong, PhD, a Gaurav Thakral, BS, a Stanley S. Franklin,
More information8/10/2012. Education level and diabetes risk: The EPIC-InterAct study AIM. Background. Case-cohort design. Int J Epidemiol 2012 (in press)
Education level and diabetes risk: The EPIC-InterAct study 50 authors from European countries Int J Epidemiol 2012 (in press) Background Type 2 diabetes mellitus (T2DM) is one of the most common chronic
More informationORIGINAL INVESTIGATION. Evaluation of the Framingham Risk Score in the European Prospective Investigation of Cancer Norfolk Cohort
ORIGINAL INVESTIGATION Evaluation of the Framingham Risk Score in the European Prospective Investigation of Cancer Norfolk Cohort Does Adding Glycated Hemoglobin Improve the Prediction of Coronary Heart
More informationSupplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups
Supplemental Table S1: Unadjusted and Adjusted Hazard Ratios for Diabetes Associated with Baseline Factors Considered in Model 3 SMART Participants Only Unadjusted Adjusted* Baseline p-value p-value Covariate
More informationHIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES
HIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES A study published in the British Medical Journal shows that not only is high LDL cholesterol not a risk factor for all-caused
More informationWhat s New in Cardiac Testing?
What s New in Cardiac Testing? Payam Dehghani, MD, FRCPC; Dobri Hazarbasanov, MD; and Andrew Ignaszewski, MD, FRCPC Presented at UBC s Diabetes and Cardiology Update, 2003 Susan s concern Susan, 55, comes
More informationMagnesium intake and serum C-reactive protein levels in children
Magnesium Research 2007; 20 (1): 32-6 ORIGINAL ARTICLE Magnesium intake and serum C-reactive protein levels in children Dana E. King, Arch G. Mainous III, Mark E. Geesey, Tina Ellis Department of Family
More informationPredicting cardiovascular risk in the elderly in different European countries
European Heart Journal (2002) 23, 294 300 doi:10.1053/euhj.2001.2898, available online at http://www.idealibrary.com on Predicting cardiovascular risk in the elderly in different European countries S.
More informationTotal risk management of Cardiovascular diseases Nobuhiro Yamada
Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible
More informationDisclosure. No relevant financial relationships. Placebo-Controlled Statin Trials
PREVENTING CARDIOVASCULAR DISEASE IN WOMEN: Current Guidelines for Hypertension, Lipids and Aspirin Disclosure Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine No relevant financial
More informationModerate alcohol consumption is associated with decreased
Alcohol Consumption and Plasma Concentration of C-Reactive Protein Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Moderate alcohol intake has been associated with
More information